Industry-led Rx-360 consortium to combat threats to global supply chain
This article was originally published in Scrip
Executive Summary
Pharmaceutical and biotech companies, including their suppliers of ingredients and components, are forming a new consortium, known as Rx-360, to help thwart threats to the global supply chain like the adulterated heparin linked to deaths in the US and Europe last year. Those leading the consortium believe companies must take more responsibility because the WHO cannot police the supply chain by itself.